Insider · CIK 0001283215

PATTI JOSEPH M

Reports to the SEC for 3 companies · LOS ANGELES, CA

sec.gov

Transactions

Companies

Filings

CIK

0001283215

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-09	ARMPArmata Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+25.6K sh	—	—	25,640
2025-02-05	ARMPArmata Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+54.3K sh	—	—	54,343
2024-03-14	ARMPArmata Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+39.7K sh	—	—	39,666
2024-03-14	ARMPArmata Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+54.3K sh	—	—	94,009
2023-12-21	ARMPArmata Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,461
2022-04-13	ARMPArmata Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+33K sh	—	—	33,000
2021-06-07	ARMPArmata Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28K sh	—	—	28,000
2020-12-08	ARMPArmata Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,000
2019-05-22	ARMPArmata Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27.4K sh	—	—	27,383
2017-04-03	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+650K sh	$0.66	+$426K	2,113,304
2016-08-11	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+380K sh	$1.30	+$494K	1,478,929
2015-09-25	VXRTVaxart, Inc.P Purchase	Director, CEO	PPurchase	+2,500 sh	$1.89	+$4,712.5	123,628
2015-09-25	VXRTVaxart, Inc.P Purchase	Director, CEO	PPurchase	+2,500 sh	$1.85	+$4,625	126,128
2015-08-11	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+250K sh	—	—	250,000
2015-03-27	VXRTVaxart, Inc.P Purchase	Director, CEO	PPurchase	+10K sh	$2.27	+$22.7K	111,128
2015-03-27	VXRTVaxart, Inc.P Purchase	Director, CEO	PPurchase	+10K sh	$2.30	+$23K	121,128
2014-10-01	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	Director, CEO	AAward	+475K sh	$2.45	+$1.16M	475,000
2014-06-30	VXRTVaxart, Inc.P Purchase	Director, CEO	PPurchase	+10K sh	$2.86	+$28.6K	68,241
2013-12-05	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+62.5K sh	—	—	62,500
2013-12-05	VXRTVaxart, Inc. · Market Stock UnitsA Award	Director, CEO	AAward	+15.6K sh	—	—	15,625
2012-11-12	VXRTVaxart, Inc.A Award	Director, CEO	AAward	+71.7K sh	—	—	71,661
2012-11-12	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+358K sh	—	—	358,304
2012-02-13	INHIBITEX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−117K sh	—	—	0
2012-02-13	INHIBITEX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−300K sh	—	—	0
2012-02-13	INHIBITEX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−225K sh	—	—	0
2012-02-13	INHIBITEX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−210K sh	—	—	0
2011-11-04	INHIBITEX, INC.S Sale	Chief Scientific Officer	SSale	−175K sh	$7.79	−$1.36M	0
2011-11-04	INHIBITEX, INC.S Sale	Chief Scientific Officer	SSale	−35K sh	$8.00	−$280K	0
2011-11-04	INHIBITEX, INC.Stock OptionX Exercise of In-Money	Chief Scientific Officer	XExercise of In-Money	−35K sh	$2.05	−$71.8K	0
2011-09-14	INHIBITEX, INC.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+105K sh	$3.23	+$339K	105,000
2011-09-14	INHIBITEX, INC.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+105K sh	$3.23	+$339K	105,000
2011-04-12	INHIBITEX, INC.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+63K sh	$1.00	+$63K	63,000
2010-12-31	INHIBITEX, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+12.6K sh	$2.64	+$33.3K	174,596
2010-12-31	INHIBITEX, INC.Stock Option (Right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−12.6K sh	$0.68	−$8,572.08	0
2010-10-04	INHIBITEX, INC.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+113K sh	$1.78	+$201K	112,500
2010-10-04	INHIBITEX, INC.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+113K sh	$1.78	+$201K	112,500
2010-04-12	INHIBITEX, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+22.7K sh	$1.67	+$37.8K	161,990
2010-04-12	INHIBITEX, INC.Stock Option (Right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−22.7K sh	$0.29	−$6,569.95	0
2009-11-04	INHIBITEX, INC.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+54K sh	$1.00	+$54K	54,000
2009-11-04	INHIBITEX, INC.Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+126K sh	$1.00	+$126K	126,000
2007-09-19	INHIBITEX, INC.Common Stock Opiton (Right to Buy)A Award	Chief Scientific Officer	AAward	+300K sh	$1.45	+$435K	300,000
2006-01-13	INHIBITEX, INC.S Sale	Chief Scientific Officer	SSale	−35K sh	$9.04	−$316K	34,600
2006-01-10	INHIBITEX, INC.S Sale	Chief Scientific Officer	SSale	−27.7K sh	$9.00	−$249K	111,950
2005-02-02	INHIBITEX, INC.Stock OptionA Award	Chief Scientific Officer	AAward	+92.5K sh	$9.07	+$839K	92,500

Recent filings

Accepted (ET)
Mar 114
PATTI JOSEPH M0001104659-26-026586
SEC(opens sec.gov)
Feb 74
PATTI JOSEPH M0001104659-25-010564
SEC(opens sec.gov)
Mar 184
PATTI JOSEPH M0001104659-24-035732
SEC(opens sec.gov)
Dec 264
PATTI JOSEPH M0001104659-23-129368
SEC(opens sec.gov)
Apr 154
PATTI JOSEPH M0001104659-22-046446
SEC(opens sec.gov)
Jun 94
PATTI JOSEPH M0001104659-21-078787
SEC(opens sec.gov)
Dec 94
PATTI JOSEPH M0001104659-20-133643
SEC(opens sec.gov)
May 244
PATTI JOSEPH M0001144204-19-028257
SEC(opens sec.gov)
Apr 54
Aviragen Therapeutics, Inc.0001437749-17-006117
SEC(opens sec.gov)
Aug 124
Aviragen Therapeutics, Inc.0001437749-16-037322
SEC(opens sec.gov)
Sep 284
Biota Pharmaceuticals, Inc.0001437749-15-017766
SEC(opens sec.gov)
Aug 134
Biota Pharmaceuticals, Inc.0001437749-15-015759
SEC(opens sec.gov)
Mar 314
Biota Pharmaceuticals, Inc.0001437749-15-006450
SEC(opens sec.gov)
Oct 24
Biota Pharmaceuticals, Inc.0001209191-14-061073
SEC(opens sec.gov)
Jul 24
Biota Pharmaceuticals, Inc.0001209191-14-044978
SEC(opens sec.gov)
Dec 94
Biota Pharmaceuticals, Inc.0001209191-13-055958
SEC(opens sec.gov)

Companies

Address

5005 MCCONNELL AVENUE

LOS ANGELES, CA, 90066